Van Cleef Asset Management,Inc Boston Scientific Corp Transaction History

Van Cleef Asset Management,Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $244,700 - $272,297	-5,935 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$33.15 - $41.97 $8,784 - $11,122	-265 Reduced 4.27%	5,935 $213,000
Q2 2020 Aug 17, 2020	SELL	$30.19 - $39.11 $1,358 - $1,759	-45 Reduced 0.72%	6,200 $218,000
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $9,040 - $15,998	-350 Reduced 5.31%	6,245 $204,000
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $14,108 - $15,207	-350 Reduced 5.04%	6,595 $268,000
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $30,460 - $37,478	960 Added 16.04%	6,945 $245,000
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $91,759 - $107,970	-2,795 Reduced 31.83%	5,985 $230,000
Q2 2018 Aug 10, 2018	SELL	$26.84 - $34.32 $3,220 - $4,118	-120 Reduced 1.35%	8,780 $287,000
Q1 2018 May 04, 2018	SELL	$25.2 - $28.54 $12,600 - $14,270	-500 Reduced 5.32%	8,900 $243,000
Q3 2017 Oct 27, 2017	BUY	$26.26 - $29.17 $246,844 - $274,198	9,400	9,400 $274,000

1,448

1.21B

8.14M

8.3M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $119B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Van Cleef Asset Management,Inc, based on Form 13F filings with the SEC.

Stay updated on Van Cleef Asset Management,Inc with notifications on news.